secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXOZYMES INC. (EXOZ)
CIK:        0002010788
Form:       8-K
Filed at:   2026-02-05T23:59:59+00:00
Accession:  0001493152-26-005176
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

eXoZymes reports 535g NCT pilot run at 99% conversion, 90% yield, 99.6% purity
------------------------------------------------------------------------------

- Achieved ~99% reaction conversion, 90% isolated yield, and 535 g of NCT at 99.6% pharma-grade purity from a 100L pilot run.
- Production executed externally by Cayman Chemical, demonstrating protocol transferability and operational robustness.
- High-purity NCT is now available for formulation development and partner sample requests.
- Company expects 2026 focus on commercial NCT supply chain, expanded volumes, and strategic partnerships.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2010788/000149315226005176/0001493152-26-005176-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2010788/000149315226005176/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-005176

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer